OPTOMYCIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Optomycin, and what generic alternatives are available?
Optomycin is a drug marketed by Optopics and is included in one NDA.
The generic ingredient in OPTOMYCIN is chloramphenicol. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol profile page.
Summary for OPTOMYCIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 122 |
Patent Applications: | 4,228 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OPTOMYCIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for OPTOMYCIN
US Patents and Regulatory Information for OPTOMYCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Optopics | OPTOMYCIN | chloramphenicol | SOLUTION/DROPS;OPHTHALMIC | 062171-001 | Mar 31, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |